Search results
Apr 17, 2024 · You can't expect your account managers to sell seven or eight different offerings. If someone comes from life sciences, they struggle when they have to sell academia and other parts of the business, and vice versa.
Dec 1, 2021 · Clarivate has acquired ProQuest for $5.3 billion, including repayment of ProQuest debt. The consideration for the acquisition is approximately $4.0 billion in cash and $1.3 billion of equity. Reaffirmed Clarivate Standalone Outlook for 2021 and Combined Outlook for 2022 (forward-looking statements)
May 17, 2021 · The combination of these two gold-standard organizations will provide a gateway to the world's largest collection of interoperable, expertly curated content, including journal content, primary sources, dissertations, news, streaming video and more across multiple academic disciplines.
May 17, 2021 · This acquisition will provide Clarivate with access to complementary markets and varied users, including public libraries, research libraries, school districts and community colleges, with the opportunity to deliver new campus-wide platforms to provide a unified source of knowledge discovery.
Purpose. To elevate the ideas that will benefit everyday life. Vision. To fuel the world’s greatest breakthroughs by harnessing the power of human ingenuity. Mission. To advance the success of people and organizations through transformative intelligence and trusted partnership. Areas of opportunity and expertise.
Sep 20, 2024 · Why Clarivate? Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit clarivate.com.
People also ask
What does Clarivate do?
What makes Clarivate a great company?
Why is Clarivate acquiring ProQuest?
What services does Clarivate offer?
We’re partners to some of the world’s top institutions, organizations and brands and our data is trusted to inform national and regional research assessments and to identify the Top 100 Innovators, the most Highly Cited Researchers and the blockbuster Drugs to Watch each year.
